Important Update for Geron Corporation Investors: Class Action Lawsuit Reminder

Important Announcement for Geron Corporation Investors

The Gross Law Firm recently issued a critical reminder for shareholders of Geron Corporation (NASDAQ: GERN), emphasizing the importance of a pending class action lawsuit. For those who acquired shares of GERN during the designated class period, which spans from February 28, 2024, to February 25, 2025, this notice serves as an important opportunity for affected investors to engage in potential recovery.

Understanding the Class Action Lawsuit

Shareholders are encouraged to reach out to The Gross Law Firm to discuss the possibility of being appointed as a lead plaintiff. However, it is important to note that appointing a lead plaintiff is not a prerequisite for participating in any recoveries from this case. The deadline to register as a lead plaintiff is set for May 12, 2025.

Allegations Against Geron Corporation

The allegations presented in the lawsuit center around the concerns that Geron Corporation's executives may have misrepresented material information regarding their expectations for the drug Rytelo (imetelstat). The firm had previously showcased confidence in their ability to address an unmet medical need while executing their commercial strategy effectively.

Unfortunately, on February 26, 2025, Geron revealed disappointing financial results for the fourth quarter of the fiscal year 2024. These results disclosed that the anticipated growth of Rytelo had plateaued, which the company attributed to several factors including increasing competition, lack of market awareness, seasonality, and the burdensome monitoring requirements linked to the drug.

Following this announcement, Geron's stock saw a significant decline, dropping from $2.37 per share on February 25 to $1.61 per share the next day, highlighting a staggering decrease of approximately 32.07% in just 24 hours.

What Shareholders Should Do

It is imperative for shareholders who believe they are eligible to register for this class action lawsuit to act promptly. They can submit their details through the registration link provided by The Gross Law Firm, which will also involve monitoring services that ensure investors are kept up-to-date with the status of their case throughout its progression.

Zero Cost to Participants

For those considering participation, it is crucial to understand that registering for this class action poses no cost or obligation to the shareholders involved. The Gross Law Firm operates with a mission to uphold the rights of investors who have suffered due to fraudulent practices or deceitful information provided by companies.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its dedication to addressing class actions, focusing on rectifying financial harm brought upon investors through illicit corporate practices. Their commitment lies in ensuring transparent and responsible business conduct within corporations, striving to hold them accountable for any false or misleading statements that might lead to stock inflation.

For inquiries, shareholders are encouraged to contact The Gross Law Firm directly: 15 West 38th Street, 12th floor, New York, NY, 10018 or via email at info@grosslawfirm.com. Investors can also reach out by phone at 646-453-8903 for further assistance.

Stay vigilant, informed, and empowered as we navigate through this significant legal event impacting Geron Corporation.

Conclusion

Ultimately, this reminder serves to highlight the necessity for shareholders of Geron Corporation to register and partake in the class action lawsuit. It opens the door for potential recovery while underscoring the collaborative effort needed to seek justice for those affected by the company’s downward trajectory in stock value following the announcement of disappointing financial news.

Make sure to act before the May 12, 2025, deadline and engage with The Gross Law Firm for further guidance and support.